Renal damage after liver transplantation.
Transplantation
acute kidney injury
cirrhosis
renal replacement
Journal
Bioscience reports
ISSN: 1573-4935
Titre abrégé: Biosci Rep
Pays: England
ID NLM: 8102797
Informations de publication
Date de publication:
31 01 2020
31 01 2020
Historique:
received:
09
05
2019
revised:
23
11
2019
accepted:
16
12
2019
pubmed:
19
12
2019
medline:
17
3
2021
entrez:
19
12
2019
Statut:
ppublish
Résumé
Patients following liver transplantation are at risk to develop acute kidney injury (AKI). The aim of our study was to assess risk factors for the development of AKI and the impact of AKI on the outcome of patients after liver transplantation (OLT). In this retrospective study, we analyzed 149 patients undergoing OLT from 1/2004 to 12/2007. AKI was defined according to the KDIGO definition representing the AKIN and the RIFLE classification, and according to the need for renal replacement therapy (RRT). According to the AKIN criteria alone 14 patients, according to the RIFLE criteria alone no patient and according to both definitions 30 patients developed AKI. RRT was required in 54 patients experiencing AKI, whereas 51 patients did not develop AKI. Pre OLT serum creatinine (SCr) significantly predicted the development of AKI requiring RRT, but not AKI without RRT requirement. Survival rate was significantly inferior after 28 days, one or three years in patients with AKI requiring RRT (70.4, 46.4, 44.4% vs. 100, 92.2, 90.2%, P < 0.001). There was no difference in survival between patients experiencing AKI according to the RIFLE or AKIN criteria without RRT requirement and patients without AKI. Pre OLT renal dysfunction assessed by SCr was the most important risk factor predicting severe forms of AKI, but not milder forms of AKI. AKI requiring RRT had a detrimental impact on patients' survival, whereas milder forms of AKI were not associated with a worse outcome.
Sections du résumé
BACKGROUND
Patients following liver transplantation are at risk to develop acute kidney injury (AKI). The aim of our study was to assess risk factors for the development of AKI and the impact of AKI on the outcome of patients after liver transplantation (OLT).
PATIENTS AND METHODS
In this retrospective study, we analyzed 149 patients undergoing OLT from 1/2004 to 12/2007. AKI was defined according to the KDIGO definition representing the AKIN and the RIFLE classification, and according to the need for renal replacement therapy (RRT).
RESULTS
According to the AKIN criteria alone 14 patients, according to the RIFLE criteria alone no patient and according to both definitions 30 patients developed AKI. RRT was required in 54 patients experiencing AKI, whereas 51 patients did not develop AKI. Pre OLT serum creatinine (SCr) significantly predicted the development of AKI requiring RRT, but not AKI without RRT requirement. Survival rate was significantly inferior after 28 days, one or three years in patients with AKI requiring RRT (70.4, 46.4, 44.4% vs. 100, 92.2, 90.2%, P < 0.001). There was no difference in survival between patients experiencing AKI according to the RIFLE or AKIN criteria without RRT requirement and patients without AKI.
CONCLUSION
Pre OLT renal dysfunction assessed by SCr was the most important risk factor predicting severe forms of AKI, but not milder forms of AKI. AKI requiring RRT had a detrimental impact on patients' survival, whereas milder forms of AKI were not associated with a worse outcome.
Identifiants
pubmed: 31851363
pii: 221614
doi: 10.1042/BSR20191187
pmc: PMC6944654
pii:
doi:
Substances chimiques
Biomarkers
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2020 The Author(s).
Références
J Am Soc Nephrol. 2003 Aug;14(8):2178-87
pubmed: 12874474
Ann Intern Med. 1984 Mar;100(3):352-7
pubmed: 6364908
Z Gastroenterol. 2011 Jan;49(1):30-8
pubmed: 21225535
PLoS One. 2013 May 23;8(5):e64089
pubmed: 23717537
Am J Kidney Dis. 2005 Dec;46(6):1038-48
pubmed: 16310569
Ren Fail. 2003 Jul;25(4):553-60
pubmed: 12911159
Circulation. 2009 May 12;119(18):2444-53
pubmed: 19398670
Transplant Rev (Orlando). 2008 Jan;22(1):82-8
pubmed: 18631861
Crit Care. 2004 Aug;8(4):R204-12
pubmed: 15312219
Nephron. 1990;55(2):121-8
pubmed: 2362625
Gastroenterology. 1987 Jul;93(1):148-56
pubmed: 3556303
Am J Transplant. 2007 Jan;7(1):168-76
pubmed: 17109735
Am J Transplant. 2008 Nov;8(11):2243-51
pubmed: 18808402
Transplantation. 2001 May 27;71(10):1424-8
pubmed: 11391230
Crit Care. 2013 Feb 06;17(1):R25
pubmed: 23388612
Hepatology. 2001 Feb;33(2):464-70
pubmed: 11172350
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1509-15
pubmed: 19574560
J Am Soc Nephrol. 2006 Oct;17(10):2871-7
pubmed: 16928802
Am J Transplant. 2009 Mar;9(3):610-3
pubmed: 19260838
Am J Transplant. 2006 Apr;6(4):783-90
pubmed: 16539636
Nephron Clin Pract. 2011;117(4):c305-11
pubmed: 20861652
Kidney Int. 2006 Mar;69(6):1073-80
pubmed: 16528257
Transplantation. 2006 Aug 15;82(3):304-9
pubmed: 16906024
Liver Transpl. 2009 May;15(5):475-83
pubmed: 19399734
Liver Transpl. 2004 Nov;10(11):1379-85
pubmed: 15497160
Transplant Proc. 2010 Nov;42(9):3634-8
pubmed: 21094830
Clin Transplant. 1998 Apr;12(2):123-9
pubmed: 9575400
Transplantation. 2008 Jun 15;85(11):1564-8
pubmed: 18551060
Am J Transplant. 2012 Nov;12(11):3119-27
pubmed: 22759208
Transplantation. 2004 Oct 15;78(7):1048-54
pubmed: 15480173
Crit Care. 2007;11(2):R31
pubmed: 17331245
Clin Transplant. 2015 Jan;29(1):34-43
pubmed: 25328090
Ann Surg. 2009 May;249(5):851-8
pubmed: 19387314
Crit Care. 2006;10(3):R73
pubmed: 16696865
Liver Int. 2012 Feb;32(2):179-88
pubmed: 21745304
Crit Care Med. 2008 Apr;36(4):1129-37
pubmed: 18379238
Transplantation. 2001 Dec 27;72(12):1934-9
pubmed: 11773892
Surgery. 2008 Feb;143(2):243-51
pubmed: 18242341
Nephrol Dial Transplant. 2005 Feb;20(2):354-60
pubmed: 15598666
J Am Soc Nephrol. 2002 Jan;13(1):228-33
pubmed: 11752042
Br J Anaesth. 2015 Jun;114(6):919-26
pubmed: 25673576
Nephrol Dial Transplant. 2012 Apr;27(4):1651-7
pubmed: 22049184